Electrocardiographic abnormalities and coronary heart disease mortality among hypertensive men in the Multiple Risk
1Department of Physiology and Biophysics, Dalhousie University, Halifax, Nova Scotia.
Insights
The Multiple Risk Factor Intervention Trial found that intensive hypertension control may increase coronary heart disease death risk in hypertensive men with certain ECG abnormalities. However, an ischemic ST response to exercise showed a beneficial effect.
Area of Science:
- Cardiology
- Preventive Medicine
- Clinical Trials
Background:
- The Multiple Risk Factor Intervention Trial (MRFIT) studied 12,286 high-risk middle-aged men for primary prevention of heart attack.
- Two-thirds of participants were hypertensive at entry, with some receiving special intervention (SI) or usual care (UC).
Purpose of the Study:
- To investigate the impact of electrocardiogram (ECG) abnormalities on coronary heart disease (CHD) mortality in hypertensive men undergoing intervention.
- To determine if specific ECG findings modify the effectiveness of hypertension control.
Main Methods:
- Analysis of ECG data from the Dalhousie ECG program within the MRFIT trial.
- Comparison of CHD death risk between hypertensive SI and UC groups, stratified by ECG abnormalities.
- Statistical analysis to assess relative risks and differences between groups.
Main Results:
- Hypertensive SI men with certain resting ECG abnormalities (e.g., repolarization issues, U wave changes) showed a potentially increased risk of CHD death compared to UC.
- An ischemic ST response to exercise was associated with a lower relative risk of CHD death in SI men (1.35) versus UC men (2.96).
- Overall, hypertensive SI men with any ECG abnormalities had a higher CHD death risk (RR 3.30) than those without, while UC men showed a lower risk (RR 1.22).
Conclusions:
- The effect of ECG abnormalities on hypertension intervention response is heterogeneous.
- Resting ECG abnormalities may indicate reduced effectiveness or adverse outcomes with intensive hypertension control.
- An ischemic ST response to exercise might predict a beneficial outcome from intensive hypertension management.
Abstract:
The Multiple Risk Factor Intervention Trial (MRFIT) was a primary prevention trial involving 12,286 middle-aged men at high risk of future heart attack, about two-thirds of them considered hypertensive at entry. The mortality results suggested an increased risk of coronary heart disease (CHD) death, particularly sudden death, possibly associated with hypertension control, following a stepped-care protocol including diuretics, among hypertensive MRFIT special-intervention (SI) participants with abnormalities in their rest ECG. No such adverse association was evident in the usual care (UC) group. ECG data from the Dalhousie ECG program revealed that for nearly every ECG abnormality considered, the risk of CHD death for hypertensive SI men was greater than for hypertensive UC men. The exception to this was ischemic response to exercise, for which the associated relative risk for UC men was 2.96 and for SI men 1.35 (p = 0.03 for SI/UC difference). The risk of CHD death for SI men with any ECG abnormalities compared to those without ECG abnormalities was 3.30. For UC men the corresponding relative risk was 1.22 (p = 0.03 for difference in relative risk). The results suggest that the influence of the presence of ECG abnormalities on the response to hypertension intervention may be heterogeneous, in that certain abnormalities (particularly repolarization abnormalities at rest, and absent or low-amplitude U waves at rest and in post-exercise ECG) may be associated with an adverse response or reduced effectiveness of hypertension intervention, whereas an ischemic ST response to exercise may be associated with a beneficial response to intensive hypertension control efforts.
More Related Videos
05:03Patient Directed Recording of a Bipolar Three-Lead Electrocardiogram using a Smartwatch with ECG Function
Published on: December 11, 2019
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertension III: Clinical Manifestations and Diagnostic Studies
